Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Harvard CRISPR pioneer Chad Cowan launches $78M stem cell play By: Boston Business Journal via Business Journals November 03, 2021 at 07:00 AM EDT One of the scientific founders of CRISPR Therapeutics AG (Nasdaq: CRSP) is embarking on a mission to solve a longstanding problem in stem cell therapy: ensuring that the body does not mount an immune response to the foreign cells. Read More >> Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Harvard CRISPR pioneer Chad Cowan launches $78M stem cell play By: Boston Business Journal via Business Journals November 03, 2021 at 07:00 AM EDT One of the scientific founders of CRISPR Therapeutics AG (Nasdaq: CRSP) is embarking on a mission to solve a longstanding problem in stem cell therapy: ensuring that the body does not mount an immune response to the foreign cells. Read More >>